Detalhe da pesquisa
1.
Properties of the full random-effect modeling approach with missing covariate data.
Stat Med
; 43(5): 935-952, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128126
2.
Population Kinetics of 0.9% Saline Distribution in Hemorrhaged Awake and Isoflurane-anesthetized Volunteers.
Anesthesiology
; 131(3): 501-511, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31246604
3.
Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches.
J Pharmacokinet Pharmacodyn
; 44(4): 325-333, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389762
4.
A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative Pain.
Pharm Res
; 33(5): 1093-103, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26753622
5.
The effect of Fisher information matrix approximation methods in population optimal design calculations.
J Pharmacokinet Pharmacodyn
; 43(6): 609-619, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27804003
6.
Population Volume Kinetics in Volunteers: Reply [RETRACTED].
Anesthesiology
; 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101979
7.
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
Br J Clin Pharmacol
; 79(1): 6-17, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548174
8.
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 study.
Br J Clin Pharmacol
; 80(6): 1374-87, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218447
9.
Inter occasion variability in individual optimal design.
J Pharmacokinet Pharmacodyn
; 42(6): 735-50, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26452548
10.
Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.
J Pharmacokinet Pharmacodyn
; 41(6): 639-54, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25308776
11.
Using forest plots to interpret covariate effects in pharmacometric models.
CPT Pharmacometrics Syst Pharmacol
; 13(5): 743-758, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415822
12.
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors.
Clin Pharmacol Ther
; 115(3): 498-505, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173172
13.
Optimizing disease progression study designs for drug effect discrimination.
J Pharmacokinet Pharmacodyn
; 40(5): 587-96, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979056
14.
Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials.
Orphanet J Rare Dis
; 18(1): 391, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115074
15.
Serial correlation in optimal design for nonlinear mixed effects models.
J Pharmacokinet Pharmacodyn
; 39(3): 239-49, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415637
16.
A quantitative approach to the choice of number of samples for percentile estimation in bootstrap and visual predictive check analyses.
CPT Pharmacometrics Syst Pharmacol
; 11(6): 673-686, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353958
17.
An introduction to the full random effects model.
CPT Pharmacometrics Syst Pharmacol
; 11(2): 149-160, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984855
18.
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.
Cancer Chemother Pharmacol
; 90(1): 53-69, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771259
19.
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.
Pharmaceutics
; 14(8)2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893785
20.
Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment.
Drug Metab Dispos
; 39(5): 858-63, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289074